These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22693877)

  • 1. Direct thrombin inhibitors for the treatment of HIT.
    Bamberg K
    JAAPA; 2012 Jun; 25(6):18. PubMed ID: 22693877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin induced thrombocytopenia: diagnosis and management.
    Alaraj A; Wallace A; Tesoro E; Ruland S; Amin-Hanjani S; Charbel FT; Aletich V
    J Neurointerv Surg; 2010 Dec; 2(4):371-8. PubMed ID: 21990651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
    Warkentin TE
    Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update.
    Greinacher A; Warkentin TE
    Thromb Res; 2006; 118(2):165-76. PubMed ID: 16139874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of heparin-induced thrombocytopenia: therapeutic options and challenges in the clinical practices.
    Al-Eidan FA
    J Vasc Nurs; 2015 Mar; 33(1):10-20. PubMed ID: 25700733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heparin-induced thrombocytopenia].
    Koide M; Matsuo T
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):307-10. PubMed ID: 9833497
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.
    Abel EE; Kane-Gill SL; Seybert AL; Kellum JA
    Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
    Kodityal S; Manhas AH; Udden M; Rice L
    Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
    Greinacher A
    N Engl J Med; 2015 Jul; 373(3):252-61. PubMed ID: 26176382
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation.
    Wong JK; Tian Y; Shuttleworth P; Caffarelli AD; Reitz BA; Mora-Mangano CT
    Anesth Analg; 2010 Sep; 111(3):609-12. PubMed ID: 20686010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 17. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM; Wittkowsky AK; Wiggins BS
    Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia.
    Brieger DB; Mak KH; Kottke-Marchant K; Topol EJ
    J Am Coll Cardiol; 1998 Jun; 31(7):1449-59. PubMed ID: 9626819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.
    Smythe MA; Mehta TP; Koerber JM; Forsyth LL; Sykes E; Corbets LR; Melendy SM; Parikh R
    Am J Health Syst Pharm; 2012 Feb; 69(3):241-8. PubMed ID: 22261947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
    Lubenow N; Selleng S; Wollert HG; Eichler P; Müllejans B; Greinacher A
    Ann Thorac Surg; 2003 Feb; 75(2):577-9. PubMed ID: 12607680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.